Our Team « Alopexx

What is Alopexx?

Alopexx is an investment, management, and development company focused on health care opportunities

Our Team

Daniel R. Vlock, MD

Founder, CEO

Dr. Vlock brings extensive pharmaceutical industry and academic experience in pharmaceutical drug development. Dr. Vlock is founder and CEO of Alopexx Pharmaceuticals which developed and licensed a fully human monoclonal antibody directed against S. aureus. That antibody was recently licensed to Sanofi Aventis. He has also held senior-level medical and research positions at GPC Biotech,… Read More »

Christine de los Reyes

Pharm. D. - Vice President Strategic Planning and Business Development

Christine de los Reyes has over twenty two years of pharmaceutical experience and most recently was founder and Managing Director of BiotechPartnering Solutions, a business development consulting firm that advises life science companies on partnering strategy, search for potential partners, coordination of technical evaluation and due diligence, deal structure and transaction negotiation. In this capacity,… Read More »

Deborah Ramsdell

Vice President Development Operations and Regulatory Affairs

Deborah Ramsdell has over 20 years of experience in the design and implementation of development strategies for therapeutic drugs and biotechnology products. During her career, she has worked directly and extensively with the FDA and EMA in a wide variety of indications including Oncology, Dermatology, Cardiology, Hematology, Reproductive Medicine, Urology, Metabolism, Endocrinology, Anesthesia/Analgesia, Rheumatology, Transplantation… Read More »

Walter W. Simmers

Legal Counsel, KLP Trustee

Mr. Simmers is a corporate attorney who practices in corporate finance and securities law for high technology and emerging growth companies particularly in telecommunications, software and bio-technology. He is a member of the University of Connecticut Health Center Institutional Review Board, and has served on statewide boards and commissions for housing, transportation and business matters…. Read More »